• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Transparency in the Healthcare Sector: More Might Not Be Better

Article

New research details how to properly implement healthcare transparency and increase social welfare.

Transparency in Healthcare

Advocates of public reporting of healthcare outcomes claim that increased transparency leads to improved social welfare because patients are equipped with information to make better healthcare choices. But new research in the journal Operations Research, finds that in the short-term transparency is positive, but in the long-term it can negatively affect social welfare and increase inequality.

The research comes from INFORMS, an international association for operations research and analytics professionals.

The study, “Can Public Reporting Cure Healthcare? The Role of Quality Transparency in Improving Patient-Provider Alignment,” conducted by Soroush Saghafian of Harvard University and Wallace Hopp of the University of Michigan, found solutions for policymakers.

First, outcome information must not only be available but understandable to the public. Second, policymakers should target younger, more affluent or urban patients or those who require non-emergency treatment. Finally, public reporting efforts should be accompanied by policies aimed at incentivizing hospitals to make socially optimal investments.

Related: Americans Want Transparency in Healthcare Pricing

“Implementing these guidelines is the best way the healthcare sector can achieve the full societal benefits of transparency,” says Saghafian, a professor in the Harvard Kennedy School.

Currently, healthcare systems use various practices such as requiring a referral from primary care physicians to see a specialist to influence the alignment between patients and providers. However, while research shows patients value quality in providers, few make formal use of quality information in their choices.

“That could mean patients don’t understand or aren’t aware of the information being provided or that the healthcare sector is not using correct measures of quality,” Saghafian says. “The point is, increasing quality transparency will eventually alter patient decisions and the healthcare market. We must understand the implications of this shift and use it to identify policy options for leveraging quality transparency to improve societal outcomes.”

Currently, transparency in the short-term increases social welfare and decreases inequality among patients, but it does so at a diminished rate because higher levels of transparency becomes expensive. This study suggests that something less than full transparency is socially ideal.

Increasing quality transparency promotes increased medical specialization resulting in decreased geographical specialization and pushes hospitals to invest in their strengths rather than their weakness. Hospitals will also have more incentives to shift their investments toward quality improvement and away from pure marketing activities.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.